CeriBell outlines $111M-$115M 2026 revenue target as new neuromonitoring products launch
Source: SeekingAlpha
2026-02-25 03:48:31 ET
More on CeriBell
- CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- CeriBell, Inc. (CBLL) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow
- Seeking Alpha’s Quant Rating on CeriBell
- Historical earnings data for CeriBell
Read the full article on Seeking Alpha
For further details see:
CeriBell outlines $111M–$115M 2026 revenue target as new neuromonitoring products launch
CeriBell Inc.
NASDAQ: CBLL
CBLL Trading
2.94% G/L:
$17.87 Last:
83,674 Volume:
$17.60 Open:
CBLL Latest News
CBLL Stock Data
$771,219,395
27,079,854
2.7%
35
N/A
Medical Equipment & Supplies
Healthcare
US
Sunnyvale
